Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 2c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• BMO Capital Starts American Eagle Outfitters (AEO) at Market Perform
• GameStop beats second quarter estimates on collectibles